ArticleMolecular therapy : the journal of the American Society of Gene Therapy2025

Allogeneic stem cell-engineered EGFRvIII-specific CAR-NKT cells for treating glioblastoma with enhanced efficacy and safety.

Yan-Ruide Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.